Combined expertise: Schreiner MediPharm and Edelmann Group develop demo version of a smart packaging solution

Schreiner MediPharm has combined its expertise in innovative specialty labels and integrated solutions with folding box manufacturer Edelmann. The result is a smart medicine packaging solution with diverse digital features.

It includes the BitSecure copy detection technology for fast and reliable product authentication as well as a closure seal with an integrated NFC chip and an additional void effect for tamper evidence.

“Pharmaceutical packaging of the future” serves more purposes than merely protecting and marking medicines. Smart packaging builds a digital bridge between the manufacturer, distributor and patient because, due to digital technologies, packaging is able to communicate.

By means of diverse features, a demo version of a smart packaging solution jointly created by Schreiner MediPharm and the Edelmann Group shows pharmaceutical manufacturers the possibilities for authentication and tamper evidence of their products and thus for supply chain security and compliance with the EU Falsified Medicines Directives that has been in effect since February 2019.

BitSecure for Product Authentication

The BitSecure copy detection technology is a printed, digital security feature. BitSecure is based on a high-resolution, random pattern whose delicate details are not discernible by the naked eye.

In an attempt to copy the small random pattern with a size of just a few millimeters, the printed image will suffer a loss in precision and optical details. The pattern can be authenticated quickly and flexibly on-site using a smartphone or handheld reader, and analyzed via related software.

BitSecure is a reliable yet cost-efficient authentication technology. Due to its small size, it can be easily integrated into existing packaging or label designs.

NFC Closure Seal for Tamper Evidence

The closure seal with a void effect and an integrated NFC chip is more than a conventional seal for folding boxes. It combines analog and digital technologies and offers double tamper evidence: Before the seal’s initial opening, the user reads the NFC chip using a smartphone and related app to receive confirmation of the product’s authenticity.

If the seal is peeled off, an irreversible void effect will appear. If the user opens the packaging without previously peeling off the seal, the seal will break along the perforation.

If the NFC chip is read again, a warning on the smartphone will indicate that the packaging has been previously opened. This makes any tampering attempt clearly visible. Additionally, interactive applications for patient information and assistance may be integrated into the NFC chip.

See also

Schreiner MediPharm and Applied DNA Sciences offer forensic counterfeit-proof feature for pharma labels

Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions, now offers a new forensic authentication feature for pharmaceutical labels in cooperation with Applied DNA Sciences. SigNature DNA is a high-security feature based on DNA markers with which pharmaceutical manufacturers can protect products against counterfeiting, and patients against potential health risks.

Schreiner MediPharm develops smart blister pack for clinical trial

Schreiner MediPharm has developed a smart blister pack for digital patient compliance monitoring to enhance medication adherence by clinical trial participants. Schreiner MediPharm implemented the smart packaging solution together with the Dutch technology company ECCT (Experts in Communications and Connectivity Technology). Employment of this electronic tool to manage and track processes during clinical trials marks a milestone for the pharmaceutical manufacturer.

Schreiner MediPharm supports Biotest AG with “Late Stage Customization” service for supply chain agility

Flexible production of functional labels successfully addresses market segmentation. Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 65 years, recently implemented a special Late Stage Customization service in partnership with its customer, Biotest AG. The new process allows for faster production of functional labels on short demand. As a result, Biotest benefits from greater flexibility and is able to respond to market requirements with requisite agility, while Schreiner MediPharm assists its customer in meeting the demands of current segmentation trends in the pharmaceutical industry.

  • Isabel Thomas
  • Product Info
  • English
  • Created 05 Apr 2019
  • Modified 15 Apr 2019
  • Hits 438